Ledning | Boehringer Ingelheim SE
Ledning
Boehringer Ingelheim är ett familjeägt företag som leds av en styrelse med verkställande direktörer.
| ## Shashank Deshpande Chairman of the Board of Managing Directors with responsibility for the Human Pharma Business Unit |
*1 April 1973
Diplom-Kaufmann (Masters’ degree in Business Administration), University of Hamburg, Hamburg, Germany
Professional milestones
2024 Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit
2022 - 2023 Country Managing Director, Japan
2020 - 2022 Head of Human Pharma, Japan
2019 - 2020 Head of Specialty Care, Japan
2017 - 2019 Head of Marketing, Japan
2014 - 2017 Head of Diabetes Marketing, Japan
2012 - 2014 Global Brand Team Leader (Ingelheim, Germany)
2002 - 2012 Various roles in US and Global Marketing at Sanofi, US
1999 - 2002 Strategy consultant at Cap Gemini, Germany
| ## Michael Schmelmer Vice Chairman of the Board of Managing Directors with responsibility for Group Functions |
*17 June 1964
Master Degree in Aerospace Technologies and Mechanical Engineering, Master Degree in Industrial Engineering
Professional milestones
2019 – 2024 Member of the Board of Managing Directors with responsibility for Finance and Group Functions, Boehringer Ingelheim
2018 – 2019 Member of the Board of Managing Directors with responsibility for Finance, Boehringer Ingelheim
2016 – 2018 Founder and Managing Director of BI X, the digital lab of Boehringer Ingelheim
2012 – 2017 CIO, Corporate Senior Vice President Information Technology, Boehringer Ingelheim
2006 – 2012 Corporate Vice President IT & CIO, Infineon AG
2003 – 2006 Vice President IT Business Transformation, Infineon AG
2000 – 2003 Vice President Logistics & Supply Chain Management IT Systems, Infineon AG
1999 – 2000 Senior Director of Supply Chain Management Competence Center IT, Infineon AG
| ## Dr Paola Casarosa Member of the Board of Managing Directors with responsibility for the Innovation Unit |
*2 February 1974
PhD in Molecular Pharmacology, Vrije Universiteit Amsterdam, The Netherlands
MSc in Medicinal Chemistry, Università di Torino, Italy
Professional milestones
2020 – 2023 Global Head of Therapeutic Areas
2019 - 2020 Global Therapeutic Area Head CNS, Retinopathy and Emerging areas
2019 - Head of Research Site Biberach, Germany
2014 - 2018 Global Head of Business Development, Prescription Medicine
2013 - 2014 Head of Therapeutic Alliances and Strategic Partnerships
2010 - 2013 Global Head Business Development and Licensing for Respiratory
2004 - 2010 Various Research roles at Boehringer Ingelheim and Organon (MSD)
| ## Frank Hübler Member of the Board of Managing Directors with responsibility for Finance |
* July 18, 1971
Master of Science degree in Business Administration
from the Catholic University Eichstätt, Ingolstadt, Germany
Professional milestones
2019 – present Head of Corporate Finance, Accounting, Controlling & Tax
2017 – 2019 Head of Corporate Controlling
2015 – 2017 Project Leadership Boehringer Ingelheim CHC/ Sanofi Merial swap transaction
2013 – 2015 Head of Global Reporting & Planning
2011 – 2013 Head of Finance & Administration UK & Ireland, Bracknell, UK
2007 – 2011 Head of Controlling Regional Center Vienna, Vienna, Austria
2005 – 2007 Senior Manager Internal Auditing, Burlington, Canada
| ## Dr Armin Wiesler Member of the Board of Managing Directors with responsibility for the Animal Health Business Unit |
*12 June 1974
Doctoral and Master of Science degrees in Economics
from the Albert-Ludwigs University Freiburg, Germany
Professional milestones
2021 – 2024 Country Managing Director & Head of Animal Health Southeast Asia, Korea, Australia and New Zealand, based in Singapore
2020 Head of Animal Health, region Southeast Asia and Korea, based in Singapore
2016 – 2020 General Manager Boehringer Ingelheim & Head of Human Pharma, Thailand
2014 – 2016 Regional Business Manager U.S. and Canada, based in Ingelheim, Germany
2010 – 2014 Human Pharma marketing leadership roles in Ingelheim, Germany & Ridgefield, U.S.
2008 – 2010 Head of Corporate Strategy & PMO, Corporate Development, Ingelheim, Germany
2001 – 2007 McKinsey & Company, Germany